149 New Montgomery Street, Ste 631
San Francisco CA 94105 USA

Brain-computer interfaces

What are brain-computer interfaces?

Brain-computer interfaces (BCIs) are devices that empower communication between brain and machine, sense abnormal brain activity, or stimulate    brain circuits to improve health or enhance human experiences.

Areas of application

Addressing the increasing prevalence of neurodegenerative disorders, the growing global geriatric population, and the need to improve quality of life for people with chronic conditions by:
BCI provides an alternative to previous rehabilitation treatments for improving cognitive and sensory-motor functions.
Enhancing daily life by improving:
Providing new and better experiences, such as:
Treating diseases
Improving cognitive functions
Improving mobility
Delivering innovative therapies and new protocols
Sleep quality
Mood
Control over biases, addictions, and emotions
Mental health and human connection
Augmented reality and virtual reality (AR/VR)
Media
Gaming
Metaverses
Entertainment
IoT
Interaction with the world through thoughts
Workplace productivity

Types of BCIs

Invasive
Implanted directly in the gray matter:
– Highest quality signal
– Most precise neuromodulation
Partially invasive
Implanted inside the skull but outside the brain:
– Lower complexity
– Lower clinical risk
– Better adjustability
– Superior long-term stability
Non-invasive
External to the body:
– Least intrusive
– Safest
– High applicability
– Faster market adoption (the largest revenue generator, accounting for 86% of total BCI revenue in 2021)

Our focus
in the BCI field

Bi-directional brain implants that sense brain activity and respond intelligently with stimulation to improve health
Brain implants involving living cells combined with optical or electrical CMOS circuits to create biohybrid neural interface
Minimally invasive surgical methods
Miniature implants
Custom low-power integrated circuits to provide computing power for BCIs
New technologies for recording and stimulating small nerves in the body to alter brain states and treat disease
Brain implants that control neurons through light using genetically modified neurons
Non-invasive BCI technologies that demonstrate high efficiency
New methods for integrating complementary metal-oxide-semiconductor (CMOS) chips with electrode arrays that allow for long-term viability of implants in the body

BCI market forecast

The BCI industry is still in its early days, so it’s difficult to make detailed forecasts. But here is what market analysts and experts can already see:
Global BCI market valuation
17.16% – CAGR (2022 — 2030)
$1.52 billion
in 2021
$1.74 billion
in 2022
$6.18 billion
in 2030
BCIs for improving quality
of life for the geriatric population
Number of people aged 65 years or older
2019
2050
2050
2019
BCIs for medical applications
in 2020
in 2030
BCIs have high applicability in the treatment of sleep disorders and neurological diseases like Alzheimer’s disease and Parkinson’s disease.

They are also being used to treat dementia; 55 million people globally have dementia, and that number is expected to grow to 78 million in 2030 and 139 million in 2050.
Revenue related to medical applications
14% – CAGR
78% of hardware revenue will be generated by medical devices in 2030.
$1.014 billion
$3.4 billion
BCIs for augmented reality and virtual reality (AR/VR)
in 2020
in 2024
The speed at which the AR/VR market is developing makes it the second largest revenue stream for BCI.
Worldwide spending on AR/VR
54% – CAGR
$12 billion
$72.8 billion

Disclaimer

Some information contained herein has been obtained from third-party sources. While taken from sources believed to be reliable, Interface Fund has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation.

This content is provided for informational purposes only and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers on those matters. References to any securities or digital assets are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest. Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by Interface Fund, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results.

Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ from or be contrary to opinions expressed by others.
Disclaimer

Some information contained herein has been obtained from third-party sources. While taken from sources believed to be reliable, Interface Fund has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation.

This content is provided for informational purposes only and should not be relied upon as legal, business, investment, or tax advice. You should consult your own advisers on those matters. References to any securities or digital assets are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Furthermore, this content is not directed at nor intended for use by any investors or prospective investors, and may not under any circumstances be relied upon when making a decision to invest. Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by Interface Fund, and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results.

Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ from or be contrary to opinions expressed by others.

149 New Montgomery Street, Ste 631
San Francisco CA 94105 USA

MR Interface Fund GP LLC © 2022, all rights reserved
Made on
Tilda